scispace - formally typeset
G

Gaetano Gargiulo

Researcher at University of Naples Federico II

Publications -  70
Citations -  4320

Gaetano Gargiulo is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Sarcopenia & Internal medicine. The author has an hindex of 22, co-authored 65 publications receiving 2857 citations. Previous affiliations of Gaetano Gargiulo include Aon.

Papers
More filters
Journal ArticleDOI

Oxidative stress, aging, and diseases.

TL;DR: Given the important role of oxidative stress in the pathogenesis of many clinical conditions and aging, antioxidant therapy could positively affect the natural history of several diseases, but further investigation is needed to evaluate the real efficacy of these therapeutic interventions.
Journal ArticleDOI

Frailty predicts long‐term mortality in elderly subjects with chronic heart failure

TL;DR: Examination of the predictive role of frailty on long‐term mortality in elderly subjects with CHF found it to be a significant predictor of long-term mortality.
Journal ArticleDOI

Sarcopenia: assessment of disease burden and strategies to improve outcomes.

TL;DR: Because sarcopenia is associated with important adverse health outcomes, such as frailty, hospitalization, and mortality, several therapeutic strategies have been identified that involve exercise training, nutritional supplementation, hormonal therapies, and novel strategies and are still under investigation.
Journal ArticleDOI

Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis

TL;DR: A continuum among hypertension, coronary artery disease, atrial fibrillation and chronic heart failure with to the development of cognitive impairment and progression to dementia has been hypothesized.
Journal ArticleDOI

Biomarkers in sarcopenia: A multifactorial approach

TL;DR: In order to characterize pathophysiological mechanisms and to make a correct assessment of elderly patient with sarcopenia, a panel of biomarkers of all pathways involved should be assessed.